PeptideDB

Corypalmine 27313-86-6

Corypalmine 27313-86-6

CAS No.: 27313-86-6

Corypalmine is an alkaloid from Stephania cepharantha. Corypalmine is an antifungal drug.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Corypalmine is an alkaloid from Stephania cepharantha. Corypalmine is an antifungal drug.

Physicochemical Properties


Molecular Formula C20H23NO4
Molecular Weight 341.4009
Exact Mass 341.163
CAS # 27313-86-6
Related CAS # (-)-Corypalmine;6018-40-2
PubChem CID 185605
Appearance White to off-white solid powder
Density 1.29g/cm3
Boiling Point 501.2ºC at 760mmHg
Flash Point 256.9ºC
LogP 3.011
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 3
Heavy Atom Count 25
Complexity 461
Defined Atom Stereocenter Count 0
InChi Key BMCZTYDZHNTKPR-UHFFFAOYSA-N
InChi Code

InChI=1S/C20H23NO4/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,9-10,16,22H,6-8,11H2,1-3H3
Chemical Name

2,9,10-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-3-ol
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Effect of Ent-norsecurinine, an Alkaloid, on Spore Germination of Some Fun. Mycobiology 30(4): 225-227 (2002).

Additional Infomation (+/-)-Corypalmine has been reported in Corydalis ternata, Corydalis yanhusuo, and other organisms with data available.

Solubility Data


Solubility (In Vitro) DMSO : ~33.33 mg/mL (~97.63 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.32 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (7.32 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.9291 mL 14.6456 mL 29.2912 mL
5 mM 0.5858 mL 2.9291 mL 5.8582 mL
10 mM 0.2929 mL 1.4646 mL 2.9291 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.